• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Fundbox Appoints Hilliard Terry to Board of Directors

    6/22/21 12:00:00 PM ET
    $UPST
    $TGH
    $A
    $TLGA
    Finance: Consumer Services
    Finance
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $UPST alert in real time by email

    SAN FRANCISCO, CA, June 22, 2021 (GLOBE NEWSWIRE) -- Fundbox, the financial platform for small businesses, announced today that it has appointed Hilliard Terry to its Board of Directors. Mr. Terry is an experienced executive leader, corporate board member and advisor to private equity backed portfolio companies.  

    Mr. Terry currently serves on the board of directors of Umpqua Holdings Corporation (NASDAQ:UMPQ), a financial services company. He also serves on the board of directors of Upstart Holdings, Inc. (NASDAQ:UPST), a leading artificial intelligence consumer lending platform, and on the board of TLG Acquisition One Corporation (NYSE:TLGA), a special purpose acquisition company.

    "Hilliard is an accomplished public company CFO and a seasoned board member with an impressive record of achievement at the intersection of technology, finance, and banking," said Prashant Fuloria, CEO of Fundbox. "We are thrilled to benefit from his operating and board experience in this time of opportunity and growth post-COVID."

    Mr. Terry has recently served as an advisor to private companies and previously as Executive Vice President and Chief Financial Officer of Textainer (NYSE:TGH). Prior to Textainer, Mr. Terry was Vice President and Treasurer at Agilent Technologies (NYSE:A), and was the Head of Investor Relations during their IPO and subsequent spin-off from Hewlett-Packard. Before joining Agilent, he worked in marketing and investor relations for HP's VeriFone subsidiary. Mr. Terry has also held positions in investor relations and investment banking with Kenetech Corporation and Goldman, Sachs & Co., respectively. He is a qualified financial expert with operating experience and in-depth knowledge of accounting, treasury, investor relations, financial planning & analysis, risk management and corporate development.

    "Through their AI-powered platform, Fundbox is providing access to credit for a much broader community of small businesses, a sector that has been underserved in the past. This is critically important and fundamentally different from anything that has ever been done before," said Mr. Terry. "There is a massive market opportunity ahead and I look forward to rolling up my sleeves and diving into areas like governance and compliance, which are critical fields of investment for a company at this stage." 

    The company is poised for massive growth as the small business economy recovers and expands post-COVID. Recent research has shown that Americans started 4.4 million businesses in 2020, a 24% increase from the year prior, and the first time in history that new businesses have increased during a recession. 

    Fundbox provides access to financial tools that enable small business owners to cover business-critical operating expenses. Their AI technology has enabled the company to scale quickly through automation while increasing access to capital through superior predictions and credit decisions. Fundbox's process is fully automated, and 99% of their decisions are made without human intervention.

    About Fundbox

    Fundbox is a financial platform for small businesses. The company is on a mission to unlock growth for small businesses by providing fast and easy access to financial tools and working capital solutions.  Fundbox has connected with nearly 300,000 businesses, unlocked over $2B in working capital, and invested $100M into its AI platform, gaining deep insights into the small business ecosystem.

    The company has received numerous awards including the prestigious Forbes Best Startup Employers and AI 50, Red Herring Top North American 250, CB Insights Fintech 250, and Fintech Breakthrough Awards. Founded in 2013, Fundbox currently has 200+ employees and offices in San Francisco, CA; Dallas, TX; and Tel Aviv, Israel.



    Liz Berman
    Allison+Partners
    908-566-2090
    [email protected]
    
    Get the next $UPST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UPST
    $TGH
    $A
    $TLGA

    CompanyDatePrice TargetRatingAnalyst
    Upstart Holdings Inc.
    $UPST
    3/16/2026$43.00Neutral → Buy
    BTIG Research
    Upstart Holdings Inc.
    $UPST
    2/17/2026$30.00Sell → Neutral
    Compass Point
    Upstart Holdings Inc.
    $UPST
    2/13/2026$20.00Mkt Perform → Mkt Underperform
    Citizens
    Upstart Holdings Inc.
    $UPST
    2/13/2026$35.00Sell → Neutral
    Goldman
    Agilent Technologies Inc.
    $A
    1/20/2026$180.00Buy
    HSBC Securities
    Upstart Holdings Inc.
    $UPST
    1/6/2026$59.00Buy
    Truist
    Agilent Technologies Inc.
    $A
    1/5/2026$160.00In-line → Outperform
    Evercore ISI
    Agilent Technologies Inc.
    $A
    12/15/2025$165.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $UPST
    $TGH
    $A
    $TLGA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Blankmeyer Andrea

    4 - Upstart Holdings, Inc. (0001647639) (Issuer)

    4/2/26 4:36:10 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Henson Meghan

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    4/2/26 4:06:44 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Blankmeyer Andrea

    3 - Upstart Holdings, Inc. (0001647639) (Issuer)

    3/26/26 4:29:11 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    SEC Filings

    View All

    Agilent Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AGILENT TECHNOLOGIES, INC. (0001090872) (Filer)

    4/3/26 4:05:10 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Upstart Holdings Inc.

    SCHEDULE 13G/A - Upstart Holdings, Inc. (0001647639) (Subject)

    3/27/26 1:55:09 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Agilent Technologies Inc.

    SCHEDULE 13G/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    3/26/26 3:12:29 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Upstart upgraded by BTIG Research with a new price target

    BTIG Research upgraded Upstart from Neutral to Buy and set a new price target of $43.00

    3/16/26 8:34:06 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Upstart upgraded by Compass Point with a new price target

    Compass Point upgraded Upstart from Sell to Neutral and set a new price target of $30.00

    2/17/26 8:05:30 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Upstart downgraded by Citizens with a new price target

    Citizens downgraded Upstart from Mkt Perform to Mkt Underperform and set a new price target of $20.00

    2/13/26 8:31:11 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

    Agilent Technologies, Inc. (NYSE:A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform. Building on a decade of Cytation innovation and shaped by continuous customer feedback, the BioTek Cytation 9 helps laboratories move from samples to insights faster, supporting workflows from basic research through high‑content screening. Designed for researchers running both cell-based and biochemical assays, Cytation 9 brings expanded imaging capabilities along with advanced hybrid microplate detection technologies. Key features inc

    4/1/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

    Test enables identification of patients whose tumors express PD-L1 for potential treatment with KEYTRUDA® (pembrolizumab)1, 2 Agilent Technologies Inc. (NYSE:A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to aid in identifying patients with esophageal or gastroesophageal junction (GEJ) carcinoma who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy. PD-L1 IHC 22C3 pharmDx, Code SK006, is the only FDA-approved companion diagnostic indicated to identify patients with esophageal or GEJ carcinoma whose tumors express PD-L1 (Combined Positive Score

    3/26/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Harborstone Credit Union Selects Upstart for Personal Lending

    Harborstone Credit Union, a member-owned cooperative with over 120,000 members and approximately $3.0 billion in assets serving communities across Washington, has partnered with Upstart (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, to support its members and continued growth in personal lending. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260325149152/en/ "Harborstone has a long history of improving the financial wellness of our members while embracing innovation to expand access to affordable credit," said Robert Luettjohann, Chief Lending Officer at Harborstone Credit Union. "Partnering with U

    3/25/26 9:00:00 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Offier Gu Paul bought $3,922,800 worth of shares (100,000 units at $39.23) (SEC Form 4)

    4 - Upstart Holdings, Inc. (0001647639) (Issuer)

    11/13/25 4:31:11 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Gonsalves Rodney (Amendment)

    4/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    10/20/23 1:07:25 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Gonsalves Rodney bought $288 worth of shares (3 units at $111.09), increasing direct ownership by 0.01% to 24,222 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    9/29/23 4:03:46 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Leadership Updates

    Live Leadership Updates

    View All

    Truepic Welcomes Kerry Whorton Cooper to its Board of Advisors

    SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Truepic, the enterprise leader of Visual Risk Intelligence in the AI era, announced the addition of Kerry Whorton Cooper to its industry Board of Advisors. Cooper brings over two decades of executive leadership and board experience, scaling complex consumer, eCommerce, retail, and energy businesses. Her career centers on building trust and navigating operational risk from growth-stage technology startups to Fortune 500 companies. Cooper joins as Truepic's technology and risk management platform is being increasingly adopted to counter retail, recall, and warranty fraud. She will serve on Truepic's Board of Advisors alongside leaders in security

    1/6/26 11:00:00 AM ET
    $PCG
    $UPST
    Power Generation
    Utilities
    Finance: Consumer Services
    Finance

    Agilent Names Adam S. Elinoff as Chief Financial Officer

    Agilent Technologies Inc. (NYSE:A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective Nov. 17. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251027719923/en/Adam S. Elinoff, Chief Financial Officer, Agilent Technologies Elinoff brings two decades of financial experience spanning corporate finance, investor relations, strategy and business transformation, and has a proven record of driving enterprise-wide transformations, optimizing financial operations and scaling global capabilities. He joins Agilent from Amgen, a worldwide pioneer in biotechnology, where he advanced through a series of

    10/27/25 4:15:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

    Agilent Technologies Inc. (NYSE:A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative Agilent products and partnerships playing a crucial role in transforming cancer research, diagnostics, and therapeutics will be featured, including: Agilent Avida DNA Cancer Panels – Based on cutting-edge next-generation sequencing (NGS) target enrichment solutions that enable simultaneous DNA and methylation profiling from a single sample, the Avida product portfolio has expanded to include three new DNA panels*. Optimized based on the requirements of the European OncNGS Consortium, these catalog p

    4/24/25 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Financials

    Live finance-specific insights

    View All

    Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

    Delivers solid Q1 results, raises FY26 reported revenue outlook and increases non-GAAP EPS(3) guidance while confirming core-revenue growth(1) and margin expansion First-quarter fiscal year 2026 Revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth of 7.0% reported and up 4.4% on a core(1) basis compared with the first quarter of 2025. GAAP net income of $305 million; earnings per share (EPS) of $1.07, a decline of 4% from the first quarter of 2025. Non-GAAP(2) net income of $386 million; non-GAAP EPS(3) of $1.36, growing 4% from the first quarter of 2025. Fiscal year 2026 and second-quarter outlook Fiscal year 2026 revenue is expected in t

    2/25/26 4:05:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent Announces Cash Dividend of 25.5 Cents per Share

    Agilent Technologies Inc. (NYSE:A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on April 22, 2026, to all shareholders of record as of the close of business on March 31, 2026. The timing and amounts of future dividends are subject to the determination and approval of Agilent's board of directors. About Agilent Technologies Agilent Technologies, Inc. (NYSE:A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide t

    2/11/26 4:15:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Upstart Announces Fourth Quarter and Full Year 2025 Results

    Announces Leadership Evolution Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, today announced financial results for the quarter and full year ended December 31, 2025. Upstart will host a conference call and webcast at 1:30 p.m. Pacific Time today. An earnings presentation and link to the webcast are available at ir.upstart.com. "In 2025, we grew originations 86% and revenues 64% while growing headcount just 18% — a ratio any business would die for. And we re-established Upstart as a strongly profitable business," said Dave Girouard, Co-founder and CEO of Upstart. "Our auto and home originations each grew 5X in 2025 — and accelerated e

    2/10/26 4:03:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

    SC 13G/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 1:27:37 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 11:54:03 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/4/24 10:57:57 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials